Top compounds associated with response to LGALS9


Feature Type Standardized
Nominal ANOVA
mRNA PD318088 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.23 2e-06
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.17 2e-06
mRNA AC220 GDSC1000 pan-cancer AAC 0.17 4e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.16 8e-06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA AS605240 GDSC1000 pan-cancer AAC 0.16 1e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-05
Download CSV